Bio-Path Holdings
  • About Bio-Path
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Partnering Opportunities
  • Technology
  • Pipeline
    • Pipeline
    • Prexigebersen
    • BP1001-A
    • BP1002
    • BP1003
  • Patients
  • Investors
    • Overview
    • SEC Filings
    • Corporate Governance
  • Media
    • Press Releases
    • Events
    • Presentations & Publications
  • Careers
  • Contact Us
  • About Bio-Path
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Partnering Opportunities
  • Technology
  • Pipeline
    • Pipeline
    • Prexigebersen
    • BP1001-A
    • BP1002
    • BP1003
  • Patients
  • Investors
    • Overview
    • SEC Filings
    • Corporate Governance
  • Media
    • Press Releases
    • Events
    • Presentations & Publications
  • Careers
  • Contact Us
March 16, 2023

SEC Form 8-K: Press Release dated March 16, 2023

December 29, 2022

Delaying Amendment for Bio-Path Holdings, Inc.

December 29, 2022

SEC Form S-1

December 20, 2022

SEC Form 8-K: Election of Directors; Appointment of Officers

December 9, 2022

SEC Form 8-K: Termination of a Material Definitive Agreement

December 7, 2022

SEC Form 8-K: Press Release dated December 7, 2022

November 15, 2022

SEC Form 8-K: Press Release dated November 15, 2022

November 15, 2022

SEC Form 10-Q for Period Ending September 30, 2022

November 9, 2022

SEC Form 8-K: Prospectus Supplement

Load More
November 9, 2022

SEC Form 424B5: Prospectus Supplement

October 28, 2022

SEC Schedule 14A: Proxy Statement

October 28, 2022

SEC Schedule 14A: Information Required In Proxy Statement

October 24, 2022

SEC Form 8-K: Press Release dated October 24, 2022

September 6, 2022

SEC Form 8-K: Press Release dated September 6, 2022

August 16, 2022

SEC Form 8-K: Press Release dated August 16, 2022

August 16, 2022

SEC Form 10-Q for Period Ending June 30, 2022

July 29, 2022

SEC Form 424B5: Prospectus Supplement

June 16, 2022

SEC Form 424B5: Prospectus

June 16, 2022

SEC Form 424B5: Prospectus

June 3, 2022

SEC Form S-3: Prospectus

May 17, 2022

SEC Form 8-K: Results of Operations and Financial Condition

May 17, 2022

SEC Form 10-Q: For Period Ending March 31, 2022

April 12, 2022

SEC Form 8-K: Press Release Dated April 12, 2022

April 6, 2022

SEC Form 8-K: Change in Directors

March 11, 2022

SEC Form 8-K: Press Release Dated March 11, 2022

March 11, 2022

SEC Form 10-K: For Fiscal Period Ending December 31, 2021

March 9, 2022

SEC Form 8-K: Press Release Dated March 8, 2022

February 25, 2022

SEC Form 8-K: Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

February 18, 2022

SEC Form 8-K: Departure of Directors or Certain Officers

January 5, 2022

SEC Form 8-K: Press Release Dated January 5, 2021

December 29, 2021

SEC Form 8-K: Submission of Matters to a Vote of Security Holders

December 17, 2021

SEC Form 8-K: Item 8.01 Other Events

December 13, 2021

SEC Form 8-K: Press Release Dated December 13, 2021

November 12, 2021

SEC Form 8-K: Press Release Dated November 12, 2021

November 10, 2021

SEC Form 10-Q for period ending September 30, 2021

November 4, 2021

SEC Form Schedule 14A: Proxy Materials

November 4, 2021

SEC Form Schedule 14A: Notice of Annual Meeting

November 4, 2021

SEC Form 8-K: Press Release Dated November 4, 2021

October 27, 2021

SEC Form 8K: Press Release Dated October 27, 2021

August 24, 2021

SEC Form 8-K: Press Release dated August 24, 2021

August 19, 2021

SEC Form 424B5: PROSPECTUS SUPPLEMENT (To Prospectus dated June 5, 2019)

August 19, 2021

SEC Form 8-K: Items 8.01 & 9.01

August 13, 2021

SEC Form 8K: Press Release Dated August 13, 2021

August 13, 2021

SEC Form 10-Q for period ending June 30, 2021

June 23, 2021

SEC Form 8K: Press Release Dated June 22, 2021

May 14, 2021

SEC Form 8K: Press Release Dated May 14, 2021

May 14, 2021

SEC Form 10-Q for period ending March 31, 2021

May 14, 2021

Interactive Data 10-Q

April 23, 2021

SEC Form 8K: Press Release Dated April 22, 2021

April 14, 2021

SEC Form 8K: Press Release Dated April 12, 2021

April 6, 2021

SEC Form 8K: Press Release Dated April 6, 2021

March 11, 2021

SEC Form 8K: Press Release Dated March 11, 2021

March 10, 2021

SEC Form 8K: Press Release Dated March 10, 2021

March 10, 2021

SEC Form 10-K for Fiscal Year Ended December 31, 2020

March 10, 2021

Interactive Data 10-K

February 17, 2021

SEC Form 424B5: Prospectus Supplement (To Prospectus Dated June 5, 2019)

February 17, 2021

SEC Form 8K: Entry Into a Material Definitive Agreement and Press Release dated February 16, 2021

February 11, 2021

SEC Form 8K: Press Release Dated February 10, 2021

December 18, 2020

SEC Form 8K: Press Release Dated December 18, 2020: Submission of Matters to a Vote of Security Holders

November 20, 2020

SEC Form 8K: Press Release Dated November 19, 2020

November 13, 2020

SEC Form 8K: Press Release Dated November 13, 2020

November 13, 2020

SEC Form 10-Q for period ending September 30, 2020

November 13, 2020

Interactive Data Files

November 5, 2020

Proxy Notice Card

November 5, 2020

Proxy Statement

November 5, 2020

Annual Report 2019

October 22, 2020

SEC Form 8K: Press Release Dated October 22, 2020

September 10, 2020

SEC Form 8-K: Press Release Dated September 9, 2020

August 14, 2020

SEC Form 8-K: Press Release Dated August 14, 2020

August 14, 2020

SEC Form 10-Q for period ending June 30, 2020

August 14, 2020

Interactive Data Files

August 14, 2020

SEC Form 8-K: Press Release Dated August 13, 2020

July 14, 2020

SEC 424B5: Prospectus Supplement (To Prospectus Dated June 5, 2019)

July 14, 2020

SEC Form 8-K: Entry into a Material Agreement

July 7, 2020

SEC Form 8-K: July 6, 2020: Termination of a Material Definitive Agreement

May 29, 2020

SEC Form 8-K: Press Release Dated May 29, 2020

May 15, 2020

SEC Form 8-K: Press Release Dated May 15, 2020

May 15, 2020

SEC Form 10-Q for period ending March 31, 2020

May 15, 2020

Interactive Data Files

May 14, 2020

SEC Form 8-K: Press Release Dated May 13, 2020

April 27, 2020

SEC Form 8-K: Press Release Dated April 27, 2020

April 14, 2020

SEC Form 8-K: Press Release Dated April 13, 2020

March 11, 2020

SEC Form 8-K: Changes in Registrant’s Certifying Accountant

March 6, 2020

SEC Form 8-K: Press Release Dated March 6, 2020

March 5, 2020

SEC Form 10-K for Fiscal Year Ended December 31, 2019

March 5, 2020

Interactive Data 10-K

February 14, 2020

Schedule 13G/A

February 14, 2020

Schedule 13G/A

February 10, 2020

Schedule 13G/A

January 15, 2020

Schedule 13G/A

January 8, 2020

SEC Form 8-K: Press Release Dated January 8, 2020

December 23, 2019

SEC Form 8-K: Submission of Matters to a Vote of Security Holders

December 2, 2019

Schedule 13G

December 2, 2019

Schedule 13G

November 27, 2019

Schedule 13G

November 26, 2019

SEC Form 8-K: Press Release Dated November 26, 2019

November 25, 2019

SEC 424B5 Prospectus Supplement (To Prospectus Dated June 5, 2019)

November 25, 2019

SEC Form 8-K: Entry Into a Material Agreement

November 21, 2019

SEC Form 8-K: Press Release Dated November 21, 2019

November 15, 2019

SEC Form 8-K: Press Release Dated November 15, 2019

November 15, 2019

SEC FORM 10-Q for Period Ending September 30, 2019

November 15, 2019

Interactive Data Files for 10-Q For Period Ending September 30, 2019

November 4, 2019

Proxy Notice Card

November 4, 2019

Proxy Statement

November 4, 2019

Annual Report 2018

October 15, 2019

SEC Form 8-K: Press Release Dated October 15, 2019

September 26, 2019

SEC Form 8-K: Press Release Dated September 25, 2019

September 4, 2019

SEC Form 8-K: Press Release Dated September 3, 2019

August 27, 2019

SEC Form 8-K: Press Release Dated August 26, 2019

August 15, 2019

SEC Form 8-K: Press Release Dated August 15, 2019

August 15, 2019

SEC Form 10-Q: For Period Ended June 30, 2019

August 15, 2019

Interactive Data Files (XBRL)

June 4, 2019

SEC Form 8-K: First Amendment to Lease Agreement

May 16, 2019

SEC Form S-3

May 16, 2019

SEC Form 8-K: Press Release Dated May 16, 2019

May 15, 2019

SEC Form 10-Q: For Period Ended March 31, 2019

April 12, 2019

SEC Form for Withdrawl of Registration Statement on Form S-1

April 4, 2019

SEC Form 8-K: Press Release Dated April 3, 2019

March 20, 2019

SEC Form 8-K: Press Release Dated March 20, 2019

March 19, 2019

SEC Form 10-K for Period Ended December 31, 2018

March 19, 2019

Interactive Data Files (XBRL)

March 19, 2019

SEC Form S-1/A

March 18, 2019

SEC Form D: Notice of Exempt Offering of Securities

March 14, 2019

SEC Form 8-K: Entry Into a Material Agreement

March 14, 2019

SEC 424B5 Prospectus Supplement (To Prospectus Dated January 9, 2017)

March 6, 2019

SEC Form 8-K: Press Release Dated March 6, 2019

February 28, 2019

SEC Form 8-K: Press Release Dated February 28, 2019

February 5, 2019

Nasdaq notifying Bio-Path that it has regained compliance for continued listing on The Nasdaq Capital Market

January 25, 2019

SEC Form D

January 25, 2019

SEC Form D

January 22, 2019

SEC Form 8-K: Entry Into a Material Agreement

January 22, 2019

PROSPECTUS SUPPLEMENT (To Prospectus dated January 9, 2017)

January 16, 2019

SEC Form 8-K: Entry Into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws, Press Release dated January 14, 2019

January 16, 2019

PROSPECTUS SUPPLEMENT (To Prospectus dated January 9, 2017)

January 14, 2019

SEC 424B5 Preliminary Prospectus Supplement (To Prospectus Dated January 9, 2017)

December 28, 2018

SEC Form S-1

December 28, 2018

SEC Form S-1

December 28, 2018

SEC Form 8-K: Press Release Dated December 27, 2018

December 22, 2018

SEC Form 8-K: Submission of Matters to a Vote of Security Holders

December 4, 2018

SEC Form 8-K: Press Release Dated December 3, 2018

November 16, 2018

SEC Form 8-K: Press Release Dated November 15, 2018

November 15, 2018

SEC Form 10-Q: For Period Ended September 30, 2018

November 2, 2018

Definitive Proxy Statement – Schedule 14A

November 2, 2018

2017 Annual Report

November 2, 2018

SEC Form 8-K: Press Release Dated November 1, 2018

October 23, 2018

SEC Schedule 14A: Pre Proxy Statement – NOTICE OF ANNUAL MEETING OF STOCKHOLDERS

October 5, 2018

SEC Form D: Notice of Exempt Offering of Securities

September 21, 2018

SEC 424B5 Prospectus Supplement (To Prospectus Dated January 9, 2017)

September 21, 2018

SEC Form 8-K: Entry Into a Material Definitive Agreement

August 29, 2018

SEC Form 8-K: Press Release Dated August 29, 2018

August 28, 2018

SEC Form 8-K: Press Release Dated August 27 2018

August 16, 2018

SEC Form 8-K: Press Release Dated August 16, 2018

August 15, 2018

SEC Form 8-K: Press Release Dated August 15, 2018

August 15, 2018

SEC Form 10-Q: For Period Ended June 30, 2018

August 15, 2018

Interactive Data Files (XBRL) for 10-Q for Period Ended June 30, 2018

May 16, 2018

SEC Form 10-Q: For Period Ended March 31, 2018

May 16, 2018

Interactive Data Files (XBRL) for 10-Q for Period Ended March 31, 2018

May 16, 2018

SEC Form 8-K: Press Release Dated May 16, 2018

May 10, 2018

SEC Form 8-K: Press Release Dated May 10, 2018

April 19, 2018

SEC Form 8-K: Press Release Dated April 18, 2018

April 5, 2018

SEC Form 8-K: Press Release Dated April 3, 2018

April 3, 2018

SEC Form 8-K: Bio-Path Holdings Reports Full Year 2017 Financial Results / Press Release Dated April 3, 2018

April 2, 2018

SEC Form 10-K: For the fiscal year ended December 31, 2017

April 2, 2018

Interactive Data Files (XBRL) for 10-K for Fiscal Year Ended December 31, 2017

March 29, 2018

SEC Form 8-K: Press Release Dated March 29, 2018

March 15, 2018

SEC Form 8-K: Press Release Dated March 15, 2018

March 7, 2018

SEC Form 8-K: Press Release Dated March 6, 2018

February 26, 2018

SEC Form 8-K: In Compliance Nasdaq

February 21, 2018

SEC Form S8

February 9, 2018

SEC Form 8-K: Certificate of Amendment to Certificate of Incorporation, Press Releases Date February 5 & February 9, 2018

February 5, 2018

SEC Form 8-K: Press Release Dated February 5, 2018

January 2, 2018

SEC Form 8-K: Press Release Dated December 29, 2017

December 28, 2017

SEC Form 8-K: Submission of Matters to a Vote of Security Holders

November 16, 2017

SEC Form S3 – Registration Statement

November 9, 2017

SEC Form 10-Q: For the quarterly period ended September 30, 2017

November 9, 2017

Interactive Data Files (XBRL) for 10-Q: Period Ending September 30, 2017

November 9, 2017

SEC Form 8-K: Press Release Dated November 9, 2017

November 7, 2017

SEC Form 8-K: Press Release Dated November 6, 2017

November 6, 2017

SEC Form 8-K: Entry Into a Material Definitive Agreement

November 6, 2017

SEC 424B5: Prospectus Supplement

November 3, 2017

2016 Annual Report

November 3, 2017

Definitive Proxy Statement – Schedule 14A

October 25, 2017

SEC Schedule 14A – Preliminary Proxy Statement

September 6, 2017

SEC Form 8-K: Press Release Dated September 5, 2017

September 1, 2017

SEC Form 8-K: Nasdaq Grants Additional 180 Calendar Days to Regain Compliance

August 16, 2017

SEC Form 8-K: Departure of Directors or Certain Officers / Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

August 10, 2017

SEC Form 8-K: Press Release Dated August 10, 2017

August 9, 2017

SEC Form 10-Q: For the quarterly period ended June 30, 2017

August 9, 2017

Interactive Data Files (XBRL) for 10-Q: Period Ending June 30, 2017

July 20, 2017

SEC Form 8-K: Stockholder Letter Dated July 19, 2017

July 18, 2017

SEC Form 8-K: Press Release Dated July 17, 2017

July 17, 2017

SEC FORM 4 – Statement of Changes in Beneficial Ownership of Securities

July 17, 2017

SEC FORM 3 – Initial Statement of Beneficial Ownership of Securities

June 20, 2017

SEC Form 8-K: Stockholder Letter Dated June 20, 2017

June 19, 2017

SEC Form 8-K: Entry into a Material Definitive Agreement / Form of Warrant Amendment

June 7, 2017

SEC Form 8-K: First Amended and Restated Bylaws

May 22, 2017

SEC Form 8-K: Entry into a Material Definitive Agreement.

May 11, 2017

SEC Form 8-K: Press Release Dated May 11, 2017

May 11, 2017

SEC Form 10-Q: For the quarterly period ended March 31, 2017

May 11, 2017

Interactive Data Files (XBRL) for 10-Q: Period Ending March 31, 2017

May 2, 2017

SEC FORM 4 – Statement of Changes in Beneficial Ownership of Securities

April 17, 2017

SEC Form 8-K: Press Release Dated April 17, 2017

April 5, 2017

SEC Form 8-K: Press Release Dated April 5, 2017

March 27, 2017

SEC FORM 4 – Statement of Changes in Beneficial Ownership of Securities

March 27, 2017

SEC FORM 4 – Statement of Changes in Beneficial Ownership of Securities

March 27, 2017

SEC FORM 4 – Statement of Changes in Beneficial Ownership of Securities

March 27, 2017

SEC FORM 4 – Statement of Changes in Beneficial Ownership of Securities

March 27, 2017

SEC FORM 4 – Statement of Changes in Beneficial Ownership of Securities

March 15, 2017

SEC Form 10-K: For the fiscal year ended December 31, 2016

March 15, 2017

Interactive Data Files (XBRL) for 10-K for Fiscal Year Ended December 31, 2016

March 15, 2017

SEC Form 8-K: Press Releases Dated March 14 & March 15, 2017

March 10, 2017

SEC Form 8-K: Press Release Dated March 10, 2017

March 8, 2017

SEC Form 8-K: Failure to Satisfy a Continued Listing Rule or Standard

February 22, 2017

SEC Form 8-K: Press Release Dated February 21, 2017

February 8, 2017

SEC Form 8-K: Press Release Dated February 7, 2017

January 11, 2017

SEC 424B5 – Prospectus – Up to 5,441.176 Shares of Common Stock

January 10, 2017

SEC 424B5 – Prospectus – Up to $25,000,000 of Common Stock

December 21, 2016

SEC Form S3 – Registration Statement

December 16, 2016

SEC Form 8-K: Submission of Matters to a Vote of Security Holders. / Slide Presentation dated December 2016

December 6, 2016

SEC Form 8-K: Press Release Dated December 5, 2016

November 10, 2016

SEC FORM 8-K – for Press Release Dated November 10, 2016

November 10, 2016

SEC FORM 10-Q – For Period Ending September 30, 2016

November 10, 2016

Interactive Data for 10-Q Period Ending September 30, 2016

November 4, 2016

SEC Form 8-K: Press Releases Dated November 2, 3, & 4, 2016

October 28, 2016

Schedule 14A – Definitive Additional Materials

October 28, 2016

Schedule 14A – Definitive Proxy Statement

October 28, 2016

Annual Report on Form 10-K for the Fiscal Year Ended December 31, 2015

September 8, 2016

SEC Form 8-K: Press Release Dated September 6, 2016

August 10, 2016

SEC FORM 8-K – for Press Release Dated August 10, 2016

August 10, 2016

SEC FORM 10-Q – For Period Ending June 30, 2016

August 10, 2016

Interactive Data Files for 10-Q

August 2, 2016

SEC Form 8-K

July 6, 2016

SEC Form 8-K: Press Release Dated July 6, 2016

July 1, 2016

SEC Form 8-K: Entry Into a Material Definitive Agreement, Other Events

July 1, 2016

PROSPECTUS SUPPLEMENT (To Prospectus dated January 13, 2014)

July 1, 2016

SEC Form 8-K: Press Release Dated June 28, 2016

June 6, 2016

SEC FORM 8-K – Press Release Dated June 6, 2016

May 20, 2016

SEC FORM 8-K – Press Release Dated May 19, 2016

May 11, 2016

SEC FORM 10-Q – For Period Ending March 31, 2016

May 11, 2016

Interactive Data Files for 10-Q (Zipped)

May 11, 2016

SEC FORM 8-K – Press Release Dated May 11, 2016

May 5, 2016

SEC FORM 8-K – Press Release Dated May 5, 2016

March 24, 2016

SEC FORM 8-K – Press Release Dated March 23, 2016

March 16, 2016

SEC FORM 8-K – Press Release Dated March 15, 2016

March 15, 2016

SEC FORM 10-K – Fiscal Year Ended December 31, 2015

March 15, 2016

Interactive Data Files (XBRL) For FORM 10-K – For Fiscal Year Ending December 31, 2015

March 8, 2016

SEC FORM 8-K – Press Release Dated March 8, 2016

March 7, 2016

SEC FORM 8-K – Press Release Dated March 7, 2016

March 4, 2016

SEC FORM 8-K – Press Release Dated March 3, 2016

February 1, 2016

SEC FORM 8-K – Press Release Dated February 1, 2016

January 13, 2016

SEC FORM 8-K – Slide Presentation Dated January 2016

January 6, 2016

SEC FORM 8-K – Press Release Dated January 6, 2016

December 29, 2015

SEC FORM 8-K – Submission of Matters to a Vote of Security Holders

December 8, 2015

SEC FORM 8-K – Press Release Dated December 8, 2015

November 12, 2015

SEC SCHEDULE 14A – Definitive Proxy Statement

November 12, 2015

SEC SCHEDULE 14A ADDITIONAL PROXY MATERIAL

November 12, 2015

2014 Annual Report – SEC Form 10-K

November 10, 2015

SEC FORM 8-K – Press Release Dated November 10, 2015

November 9, 2015

SEC FORM 10-Q – For Period Ending September 30, 2015

November 9, 2015

Interactive Data Files (XBRL) For FORM 10-Q – For Period Ending September 30, 2015

November 5, 2015

SEC FORM 8-K – Press Release Dated Novembeer 5, 2015

October 14, 2015

SEC FORM 8-K – Press Release Dated October 13, 2015

October 9, 2015

SEC FORM 8-K – Press Release Dated October 9, 2015

September 2, 2015

SEC FORM 8-K – Press Release Dated September 2, 2015

September 1, 2015

SEC FORM 8-K – Press Release Dated August 31, 2015

August 12, 2015

SEC FORM 8-K – Press Release Dated August 11, 2015

August 10, 2015

SEC FORM 10-Q – Period Ending June 30, 2015

August 10, 2015

Interactive Data Files (XBRL) For FORM 10-Q – For Period Ending June 30, 2015

July 15, 2015

SEC FORM 4 – Statement of Changes in beneficial ownership of securities

July 13, 2015

SEC FORM 4 – Statement of Changes in beneficial ownership of securities

July 9, 2015

SEC FORM 4 – Statement of Changes in beneficial ownership of securities

June 25, 2015

SEC FORM 8-K – Entry into a Material Definitive Agreement, Financial Statements and Exhibits

June 25, 2015

PROSPECTUS SUPPLEMENT – To Prospectus Dated January 13, 2014

June 4, 2015

SEC FORM 8-K – Other Events

May 12, 2015

SEC FORM 8-K – Press Release Dated May 12, 2015

May 11, 2015

SEC FORM 10-Q – Period Ending March 31, 2015

May 11, 2015

Interactive Data Files (XBRL) For FORM 10-Q – For Period Ending March 31, 2015

May 4, 2015

SEC FORM 4 – Statement of changes in beneficial ownership of securities

April 28, 2015

SEC FORM 8-K – Press Release Dated April 28, 2015

April 24, 2015

SEC FORM 8-K – Press Release Dated April 24, 2015

April 22, 2015

SEC FORM 8-K – Press Release Dated April 22, 2015

April 16, 2015

SEC FORM 8-K – New Form of Indemnification Agreement

March 17, 2015

SEC FORM 8-K – Press Release Dated March 17, 2015

March 16, 2015

SEC FORM 10-K – Fiscal Year Ended December 31, 2014

March 16, 2015

Interactive Data Files (XBRL) For FORM 10-K – For Fiscal Year Ending December 31, 2014

March 6, 2015

SEC FORM 4 – Statement of changes in beneficial ownership of securities

March 5, 2015

SEC FORM 8-K – Press Release Dated March 5, 2015

March 4, 2015

SEC FORM 4 – Statement of changes in beneficial ownership of securities

March 4, 2015

SEC FORM 4 – Statement of changes in beneficial ownership of securities

March 4, 2015

SEC FORM 4 – Statement of changes in beneficial ownership of securities

March 4, 2015

SEC FORM 4 – Statement of changes in beneficial ownership of securities

February 10, 2015

SEC FORM 8-K – Press Release Dated February 9, 2015

January 8, 2015

SEC FORM 8-K – Press Release Dated January 6, 2015

January 6, 2015

SEC FORM 8-K – Material Modification to Rights of Security Holders, Amendments, to Articles of Incorporation or Bylaws: Change in Fiscal Year, Submission of Matters to a Vote of Security Holders

December 23, 2014

SEC FORM 8-K – Press Release Dated December 22, 2014

November 14, 2014

FORM 10-Q – Period Ending September 30, 2014

November 14, 2014

Interactive Data Files (XBRL) For FORM 10-Q – For Period Ending September 30, 2014

November 13, 2014

SEC SCHEDULE 14A – Definitive Proxy Statement

November 12, 2014

SEC FORM 3 – Initial Statement of Beneficial Ownership of Securities

October 9, 2014

SEC FORM 8-K – Press Release Dated October 7, 2014

October 3, 2014

SEC FORM 4 – Statement of changes in beneficial ownership of securities

October 1, 2014

SEC FORM 8-K – Press Release Dated September 30, 2014

August 20, 2014

SEC FORM 10-Q – Period Ending June 30, 2014

August 20, 2014

Interactive Data Files (XBRL) For FORM 10-Q – For Period Ending June 30, 2014

August 18, 2014

SEC FORM 8-K – Press Release Dated August 18, 2014

July 3, 2014

SEC FORM 8-K – Termination of a Material Definitive Agreement, Change in Directors or Certain Officers, Press Release Dated June 30, 2014: Bio-Path Holdings Added to Russell Global, Russell 3000 and Russell Microcap Indexes

June 20, 2014

SEC FORM 8-K – Press Release Dated June 19, 2014: Enrollment Continues Into Bio-Path Holdings Phase I Clinical Trial

May 20, 2014

SEC FORM 8-K – Press Release Dated May 16, 2014: First Quarter 2014 Operational and Financial Results

May 15, 2014

SEC FORM 10-Q – Period Ending March 31, 2014

May 15, 2014

Interactive Data Files (XBRL) For FORM 10-Q – For Period Ending March 31, 2014

May 5, 2014

SEC FORM 4 – Statement of changes in beneficial ownership of securities

April 28, 2014

SEC FORM 4 – Statement of changes in beneficial ownership of securities

April 18, 2014

SEC FORM 8-K – Entry Into a Material Definitive Agreement

April 2, 2014

SEC FORM 8-K – Press Release Dated April 1, 2014

March 31, 2014

SEC FORM 10-K – For the Fiscal Year Ended December 31, 2013

March 31, 2014

Interactive Data Files (XBRL) For FORM 10-K – For Fiscal Year Ending December 31, 2013

March 31, 2014

SEC FORM 3 – Initial Statement of Beneficial Ownership of Securities

March 26, 2014

SEC FORM 8-K – Appointment of Certain Officers, Press Release Dated March 26, 2014

March 14, 2014

SEC FORM 3/A – [Amend] Initial Statement of Beneficial Ownership of Securities

March 5, 2014

SEC FORM 8-A – Bio-Path Holdings Announces Uplisting to the NASDAQ Capital Market

March 5, 2014

SEC FORM 8-K – Press Release Dated March 5, 2014

February 13, 2014

SEC FORM 3 – Initial Statement of Beneficial Ownership of Securities

February 13, 2014

SEC FORM 4 – Statement of Changes in Beneficial Ownership of Securities

February 13, 2014

SEC FORM 8-K – Change in Directors or Principal Officers, Amendments to Articles of Incorporation or Bylaws, Change in Fiscal Year

February 3, 2014

SEC FORM 4 – Statement of Changes in Beneficial Ownership of Securities

January 21, 2014

SEC FORM 8-K – Entry into Material Definitive Agreement, Financial Statements and Exhibits

January 21, 2014

Prospectus Supplement January 15

January 21, 2014

Prospectus Supplement January 20

January 9, 2014

SEC Form S-3/A – Amendment No. 2 to Form S-3

January 7, 2014

SEC FORM 8-K – Press Release – Presentation at Biotech Showcase 2014

December 19, 2013

SEC FORM 8-K – Submission of Matters to a Vote of Security Holders

December 10, 2013

SEC FORM 8-K – Other Events, Press Release Dated December 9, 2013

December 5, 2013

SEC FORM S-3/A – Amendment No. 1 to Form S-3

November 18, 2013

SEC FORM 8-K – Press Release Dated November 15, 2013

November 18, 2013

SEC FORM 10-Q/A – Amendment No 1

November 18, 2013

XBRL FILES FOR FORM 10-Q/A – For September 30, 2013

November 14, 2013

SEC FORM 10-Q – Quarterly Report For Period Ending September 30, 2013

November 8, 2013

SEC FORM 8-K – Press Release Dated November 7, 2013

November 5, 2013

SEC FORM S-3 – Registration Statement

October 31, 2013

SEC FORM SCHEDULE 14A – Definitive Proxy Statement

October 3, 2013

SEC FORM 8-K – Unregistered Sale of Equity Securities, Press Release Dated October 1, 2013

October 2, 2013

SEC FORM 4 – Statement of changes in beneficial ownership of securities

September 20, 2013

SEC FORM 8-K – Press Release Dated September 19, 2013

August 15, 2013

SEC FORM 8-K – Press Release Dated August 15, 2013

August 15, 2013

SEC FORM 10-Q – Quarterly Report For Period Ending June 30, 2013

August 15, 2013

XBRL FILES FOR FORM 10-Q – For June 30, 2013

August 12, 2013

SEC FORM 4 – Statement of changes in beneficial ownership of securities

August 12, 2013

SEC FORM 4 – Statement of changes in beneficial ownership of securities

August 9, 2013

SEC FORM 8-K – Press Release Dated August 9, 2013

July 22, 2013

SEC FORM 8-K – Press Release Dated July 22, 2013

July 7, 2013

SEC FORM 8-K – Press Release Dated June 6, 2013

May 16, 2013

SEC FORM 8-K – Press Release Dated May 16, 2013

May 15, 2013

SEC FORM 10-Q – Period Ending March 31, 2013

May 15, 2013

XBRL FILES FOR FORM 10-Q – For March 31, 2013

April 26, 2013

SEC FORM 4 – Statement of changes in beneficial ownership of securities

April 4, 2013

SEC FORM 8-K – Press Release Dated April 2, 2013

April 1, 2013

SEC FORM 10-K – Fiscal Year Ended December 31, 2012

April 1, 2013

10-K Interactive Data Files (XBRL)

March 12, 2013

SEC FORM 8-K – Press Release Dated March 12, 2013

February 21, 2013

SEC FORM 4 – Statement of changes in beneficial ownership of securities

January 23, 2013

SEC FORM 10-K/A – Amendment No. 1 For Fiscal Year Ended December 31, 2011

January 4, 2013

SEC FORM 8-K – Press Release Dated January 3, 2013

December 17, 2012

SEC FORM 8-K – Submission of Matters to a Vote of Security Holders

December 7, 2012

SEC FORM 8-K – Press Release Dated December 6, 2012

November 16, 2012

SEC FORM 8-K – Press Release Dated Nov 14 & Nov 16, 2012

November 15, 2012

SEC FORM 10-Q – Period Ending September 30, 2012

November 15, 2012

10-Q Interactive Data Files (XBRL)

October 29, 2012

SEC SCHEDULE 14A – Definitive Proxy Statement

October 3, 2012

SEC FORM 8-K – Press Release Dated October 3, 2012 -Bio-Path Holdings to Present at 11th Annual BIO Investor Forum

October 3, 2012

SEC FORM 8-K – Press Release Dated October 3, 2012 – Press Release: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

September 5, 2012

SEC FORM 8-K – Press Release Dated September 5, 2012

August 24, 2012

SEC FORM 8-K – Press Release Dated Aug 24, 2012: Bio-Path Holdings to Present at the 2012 Southern California Investor Conference

August 16, 2012

SEC FORM 8-K – Press Release: Bio-Path Reports Second Quarter 2012 Operational and Financial Results

August 14, 2012

SEC FORM 10-Q – Period Ending June 30, 2012

August 14, 2012

10-Q Interactive Data Files (XBRL)

July 25, 2012

SEC FORM 8-K – Press Release Dated July 25, 2012

June 4, 2012

SEC FORM 8-K – Press Release Dated June 4, 2012

May 29, 2012

SEC FORM 8-K – Press Release Dated May 29, 2012

May 22, 2012

SEC FORM D – Notice of Exempt Offering of Securities

May 17, 2012

SEC FORM 8-K – Press Release Results of Operations and Financial Condition Dated May 17, 2012

May 15, 2012

SEC FORM 10-Q – Period Ending March 31, 2012

May 15, 2012

10-Q Interactive Data Files (XBRL)

May 15, 2012

PROSPECTUS SUPPLEMENT – To Prospectus Dated July 29, 2010

April 3, 2012

SEC FORM 8-K – 2011 Fiscal Year End Results and Press Release

March 30, 2012

SEC FORM 10-K – Period Ending December 31, 2011

March 30, 2012

10-K Interactive Data Files (XBRL)

February 7, 2012

SEC FORM 8-K – Press Release Bio-Path Holdings Successfully Completes Second Cohort in Phase I Clinical Trial

January 4, 2012

SEC FORM 8-K Press Release Bio-Path Holdings to Present at the Biotech Showcase 2012 Conference

November 15, 2011

SEC FORM 10-Q – Period Ending September 30, 2011

November 15, 2011

10-Q Interactive Data Files (XBRL)

November 15, 2011

SEC FORM 8-K – Press Release : 2011 3rd Quarter Financial Results

October 20, 2011

SEC FORM 8-K – Press Release : Bio-Path Holdings to Present at the 10th Annual BIO Investor Forum

October 4, 2011

SEC Form 8-K Press Release : Initial Data From Bio-Path Holdings’ Phase I Clinical Trial Accepted for Presentation at American Society of Hematology Annual Meeting

August 15, 2011

SEC Form 8-K Press Release : Financial Statements and Exhibits

August 15, 2011

SEC Form 10-Q Period Ending June 30, 2011

August 15, 2011

10-Q Interactive Data Files (XBRL)

May 17, 2011

SEC Form 10-Q Period Ending March 31, 2011

May 17, 2011

SEC Form 8-K – Press Release : Results of Financial Condition

March 31, 2011

SEC FORM 10-K – Period Ending December 31, 2010

November 15, 2010

SEC FORM 10-Q Period Ending September 30, 2010

November 9, 2010

SEC FORM 8-K Shareholder Meeting November 2010

September 20, 2010

SEC FORM 8-K – Departure of Directors or Certain Officers

August 17, 2010

SEC FORM 8-K – Exhibits – Press Release

August 16, 2010

SEC FORM 10-Q – Period Ending June 30, 2010

July 8, 2010

SEC Amendment No. 2 to Form S-1 – Registration Statement Under the Securities Act Of 1933

July 1, 2010

SEC Amendment No. 1 to Form S-1 – Registration Statement Under the Securities Act Of 1933

June 21, 2010

SEC Form 8-K – Amendments to Articles of Incorporation or Bylaws: Change in fiscal Year

June 17, 2010

SEC FORM S-1 – Registration Statement Under the Securities Act of 1933

June 4, 2010

SEC FORM 8-K – Entry into a Material Definitive Agreement, Unregistered Sale of Equity Sec

May 17, 2010

SEC FORM 10-Q – Period Ending March 31, 2010

March 31, 2010

SEC FORM 10-K – Period Ending December 31, 2009

March 15, 2010

SEC FORM 8-K – Other Events – Press release

November 15, 2009

SEC FORM 10-Q – Period Ending September 30, 2009

November 2, 2009

SEC FORM 8-K – Other Events, Exhibits

August 15, 2009

SEC FORM 10-Q – Period Ending June 30, 2009

May 18, 2009

SEC FORM 10-Q – Period Ending March 31, 2009

April 3, 2009

SEC FORM 10-K – Period Ending December 31, 2008

April 3, 2009

Exhibits for 10-K – Period Ending December 31, 2008

December 10, 2008

SEC FORM 8-S – Bio-Path Holdings, Inc. – First Amended 2007 Stock Incentive Plan

November 14, 2008

SEC Form 10-Q – Quarterly Report Period ended September 30, 2008

October 16, 2008

SEC FORM 8-K – Material Agreement, Financial Statements

October 14, 2008

SEC FORM 4

September 10, 2008

SEC Form 3

August 19, 2008

SEC FORM 8-K – Change In Directors, Principal Officers

August 14, 2008

SEC Form 10-Q – Quarterly Report Period ended June 30, 2008

June 24, 2008

SEC FORM 8-K

May 20, 2008

SEC Form 10-Q – Quarterly Report Period ended March 31, 2008

May 19, 2008

SEC FORM 8-K/A – Exhibits, Audited Financial Statements

March 3, 2008

SEC Form 8-K – Changes In Registrant’s Certifying Accountant

February 19, 2008

SEC FORM 8-K – Completion of Acquisition or Disposition of Assets

Bio-Path Holdings

All Rights Reserved

Office:

4710 Bellaire Blvd, Suite 210
Bellaire, TX 77401

T: (832) 742-1357

R&D:

5455 Dashwood Street, Suite 300
Bellaire, TX 77401

T: (832) 742-1357

logo
  • About Bio-Path
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Partnering Opportunities
  • Technology
  • Pipeline
    • Pipeline
    • Prexigebersen
    • BP1001-A
    • BP1002
    • BP1003
  • Patients
  • Investors
    • Overview
    • SEC Filings
    • Corporate Governance
  • Media
    • Press Releases
    • Events
    • Presentations & Publications
  • Careers
  • Contact Us